MED17
protein-codingmediator complex subunit 17, the group of Mediator complex
Gene summary
The activation of gene transcription is a multistep process that is triggered by factors that recognize transcriptional enhancer sites in DNA. These factors work with co-activators to direct transcriptional initiation by the RNA polymerase II apparatus. The protein encoded by this gene is a subunit of the CRSP (cofactor required for SP1 activation) complex, which, along with TFIID, is required for efficient activation by SP1. This protein is also a component of other multisubunit complexes e.g. thyroid hormone receptor-(TR-) associated proteins which interact with TR and facilitate TR function on DNA templates in conjunction with initiation factors and cofactors. [provided by RefSeq, Jul 2008]
- CRSP6
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~30.7 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0013351
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0013351
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0013351
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0013351
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0013351
Submitter: Natera
Clinical Genomic Database (CGD)
Manifestation: Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to MED17 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_004268.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 8 | 228 | 7 | 243 | ||
| missense | 3 | 175 | 13 | 191 | ||
| nonsense | 15 | 18 | 2 | 35 | ||
| start loss | 0 | |||||
| frameshift | 19 | 11 | 30 | |||
| splice donor/acceptor (+/-2bp) | 21 | 1 | 22 | |||
| Total | 34 | 53 | 186 | 241 | 7 | 521 |
Highest pathogenic variant AF is 0.00005392406
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_004259.3 | 12 | MANE Select | |
| Ensembl | ENSP00000251871.3 | 12 | MANE Select | |
| Ensembl | ENSP00000433626.2 | 2 | Standard | |
| Ensembl | ENSP00000433090.2 | 10 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Thyroid hormone signaling pathway - Homo sapiens (human)
- Developmental Biology
- Gene expression (Transcription)
- Generic Transcription Pathway
- RNA Polymerase II Transcription
Biological Process
- regulation of transcription by RNA polymerase II
- transcription initiation from RNA polymerase II promoter
- intracellular steroid hormone receptor signaling pathway
- androgen receptor signaling pathway
- positive regulation of transcription, DNA-templated
Molecular Function
- transcription coregulator activity
- transcription coactivator activity
- protein binding
- nuclear receptor transcription coactivator activity
- signaling receptor activity
Cellular Component
- nucleus
- nucleoplasm
- transcription factor complex
- membrane
- mediator complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000251871
- Coding exons
- 12
- Length
- 30469
- Individuals with no LoFs
- 125700
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 47
- Defined
- 125747
- p
- 0.000187
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.878 | 298 | 344 | 0.867 | 0.0000172 | 4263 |
| Missense (PolyPhen) | 71 | 90.435 | 0.7851 | 1127 | ||
| Synonymous | 0.598 | 116 | 124 | 0.932 | 0.00000613 | 1218 |
| Loss of Function | 2.63 | 20 | 37.3 | 0.536 | 0.00000208 | 395 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00031 | 0.00031 | rare |
| Latino/Admixed American | 0.000087 | 0.000087 | rare |
| Ashkenazi Jewish | 0.000099 | 0.000099 | rare |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00029 | 0.00028 | rare |
| South Asian | 0.00016 | 0.00016 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. {ECO:0000269|PubMed:16595664}.;
Recessive Scores
- pRec
- 0.131
Intolerance Scores
- LoFtool
- 0.864
- RVIS EVS
- -0.78
- RVIS percentile EVS
- 12.88
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- E
- Essential (gene trap)
- E
- Indispensability pred.
- E
- Indispensability score
- 0.768
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |